Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:November 19, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:November 19, 2018Completed
Condition(s):HIV-1 InfectionLast Updated:March 4, 2020Completed
Condition(s):HIV; HBVLast Updated:November 16, 2018Completed
Condition(s):HIV-1-infectionLast Updated:June 5, 2023Active, not recruiting
Condition(s):Hiv; TransgenderismLast Updated:March 26, 2024Recruiting
Condition(s):HIV/AIDSLast Updated:August 13, 2021Completed
Condition(s):HealthyLast Updated:November 30, 2016Completed
Condition(s):HIVLast Updated:October 31, 2019Completed
Condition(s):HIV-1 InfectionLast Updated:February 6, 2023Active, not recruiting
Condition(s):Hepatitis B Infection; Malignant Solid NeoplasmLast Updated:March 27, 2024Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.